Skip to content

PMCF Study on CranioFix®2 System Used for the Fixation of Craniotomized Bone Flaps and Fractures

Prospective, Single Center PMCF-study on the Performance and Safety of the CranioFix®2 System Used for the Fixation of Craniotomized Bone Flaps and Fractures to the Neurocranium

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05119595
Acronym
CRANFLAP
Enrollment
25
Registered
2021-11-15
Start date
2022-03-22
Completion date
2023-10-27
Last updated
2025-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skull Fractures

Keywords

Bone Flap Fixation, Fractures to the Neurocranium, Craniotomized bone flaps

Brief summary

The CranioFix®2 PMCF study has been set up as an action within the framework of a proactive post-market surveillance system of the manufacturer. The aim of this observational study is to collect systematically and proactively data regarding the performance of CranioFix®2, like adverse events (AEs), handling and cosmetic outcome, under daily clinical practice when used as intended by the manufacturer.

Interventions

None listed

Sponsors

Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Written informed consent * Age ≥ 18 years * Use of CranioFix®2 system according to IfU * Planned postoperative MRI within clinical routine

Exclusion criteria

* Pregnancy * Patients with hypersensitivity to metals or allergies to the implant materials * Inflammations in the region of the implant site * Bone conditions that rule out the application of CranioFix®2 titanium clamps * Use with artificial cranial bone flaps * Bone tumors in the area supporting the implant * Degenerative bone diseases * Missing dura mater * Application in the facial skull (viscerocranium) and in the orbital or skull-base region * Combination of implant components from different manufacturers, i.e. additional use of plates and screws on the same bone fragment

Design outcomes

Primary

MeasureTime frameDescription
Planarity of Bone Flap After ImplantationThrough postoperative course: at discharge (about up to 2 weeks after surgery) and post-operative follow-up (3±2 months after surgery)The primary variable was the planarity of the bone flap after implantation. The bone flap planarity was evaluated as the rate of patients in which a dislocation of the bone flap occurred - defined as the height of the tilting (depression / protrusion) greater than the bone width.

Secondary

MeasureTime frameDescription
Number of Participants With Adverse Events (Intra- and Postoperative)through study completion, an average of 3 monthsNumber of adverse events e.g. foreign body reactions, infections, injury to the dura, injury to the scalp, epiduralhaematoma, wound healing disorders with special focus on (serious) adverse events with (possible) relation to the investigational product
Overall Handling of Instruments for CranioFix®2 System Implantation Documented on a Likert ScaleintraoperativeAssessment of handling, documented on a Likert scale 1 to 5 (1 is the very good, 2 is good, 3 is acceptable, 4 is poor, 5 is very poor)
Stability of the Bone Flap After Fixationintraoperative, at discharge (about up to 2 weeks after surgery) and post-operative follow-up (3±2 months)Assessment of stability of the bone flap, documented on a Likert scale 1 to 5 (1≙very good, 2≙good, 3≙medium, 4≙poor, 5≙very poor)
Cosmetic Outcomeintraoperative, at discharge (about up to 2 weeks after surgery) and post-operative follow-up (3±2 months)Assessment of cosmetic outcome intraoperatively, at discharge and at post-operative follow-up documented on a 3 point scale (good, fair, bad)

Countries

Germany

Participant flow

Participants by arm

ArmCount
Observational Study Group
All patients that were included in the study received treatment with the investigational device according to site's clinical routine.
25
Total25

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDeath1
Overall StudyLost to Follow-up7

Baseline characteristics

CharacteristicObservational Study Group
Age, Continuous53 years
STANDARD_DEVIATION 17
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Germany
25 participants
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
17 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
1 / 25
other
Total, other adverse events
1 / 25
serious
Total, serious adverse events
2 / 25

Outcome results

Primary

Planarity of Bone Flap After Implantation

The primary variable was the planarity of the bone flap after implantation. The bone flap planarity was evaluated as the rate of patients in which a dislocation of the bone flap occurred - defined as the height of the tilting (depression / protrusion) greater than the bone width.

Time frame: Through postoperative course: at discharge (about up to 2 weeks after surgery) and post-operative follow-up (3±2 months after surgery)

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Observational Study GroupPlanarity of Bone Flap After Implantationat discharge (about up to 2 weeks after surgery)yes23 Participants
Observational Study GroupPlanarity of Bone Flap After Implantationat discharge (about up to 2 weeks after surgery)no0 Participants
Observational Study GroupPlanarity of Bone Flap After Implantationat discharge (about up to 2 weeks after surgery)could not be evaluated2 Participants
Observational Study GroupPlanarity of Bone Flap After Implantationpost-operative follow-up (3±2 months after surgery)yes17 Participants
Observational Study GroupPlanarity of Bone Flap After Implantationpost-operative follow-up (3±2 months after surgery)no0 Participants
Observational Study GroupPlanarity of Bone Flap After Implantationpost-operative follow-up (3±2 months after surgery)could not be evaluated8 Participants
Secondary

Cosmetic Outcome

Assessment of cosmetic outcome intraoperatively, at discharge and at post-operative follow-up documented on a 3 point scale (good, fair, bad)

Time frame: intraoperative, at discharge (about up to 2 weeks after surgery) and post-operative follow-up (3±2 months)

Population: At the discharge visit, in 2 cases no evaluation of the cosmetic outcome by the surgeon was available because in one case no MRI scan was conducted and in another case the patient died after surgery before discharge.~At the follow-up visit, in 8 cases, no evaluation of the cosmetic outcome was available because the follow-up visit did not take place.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Observational Study GroupCosmetic OutcomeCosmetic outcome by surgeon (surgery)good24 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by surgeon (surgery)fair1 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by surgeon (surgery)bad0 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by surgeon (surgery)could not be evaluated0 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by surgeon (discharge)good23 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by surgeon (discharge)fair0 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by surgeon (discharge)bad0 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by surgeon (discharge)could not be evaluated1 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by surgeon (follow up)good17 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by surgeon (follow up)fair0 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by surgeon (follow up)bad0 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by surgeon (follow up)could not be evaluated0 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by patient (discharge)good22 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by patient (discharge)fair1 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by patient (discharge)bad0 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by patient (discharge)could not be evaluated1 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by patient (follow up)good14 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by patient (follow up)fair3 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by patient (follow up)bad0 Participants
Observational Study GroupCosmetic OutcomeCosmetic outcome by patient (follow up)could not be evaluated0 Participants
Secondary

Number of Participants With Adverse Events (Intra- and Postoperative)

Number of adverse events e.g. foreign body reactions, infections, injury to the dura, injury to the scalp, epiduralhaematoma, wound healing disorders with special focus on (serious) adverse events with (possible) relation to the investigational product

Time frame: through study completion, an average of 3 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Observational Study GroupNumber of Participants With Adverse Events (Intra- and Postoperative)3 Participants
Secondary

Overall Handling of Instruments for CranioFix®2 System Implantation Documented on a Likert Scale

Assessment of handling, documented on a Likert scale 1 to 5 (1 is the very good, 2 is good, 3 is acceptable, 4 is poor, 5 is very poor)

Time frame: intraoperative

ArmMeasureGroupValue (NUMBER)
Observational Study GroupOverall Handling of Instruments for CranioFix®2 System Implantation Documented on a Likert Scalevery good12 participants
Observational Study GroupOverall Handling of Instruments for CranioFix®2 System Implantation Documented on a Likert Scalegood12 participants
Observational Study GroupOverall Handling of Instruments for CranioFix®2 System Implantation Documented on a Likert Scaleacceptable1 participants
Observational Study GroupOverall Handling of Instruments for CranioFix®2 System Implantation Documented on a Likert Scalepoor0 participants
Observational Study GroupOverall Handling of Instruments for CranioFix®2 System Implantation Documented on a Likert Scalevery poor0 participants
Secondary

Stability of the Bone Flap After Fixation

Assessment of stability of the bone flap, documented on a Likert scale 1 to 5 (1≙very good, 2≙good, 3≙medium, 4≙poor, 5≙very poor)

Time frame: intraoperative, at discharge (about up to 2 weeks after surgery) and post-operative follow-up (3±2 months)

Population: One of 25 patients died after surgery before discharge, 7 patients were lost to follow-up between discharge and follow up visit.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Observational Study GroupStability of the Bone Flap After Fixationsurgeryvery good19 Participants
Observational Study GroupStability of the Bone Flap After Fixationsurgerygood5 Participants
Observational Study GroupStability of the Bone Flap After Fixationsurgeryacceptable1 Participants
Observational Study GroupStability of the Bone Flap After Fixationsurgerycould not be evaluated0 Participants
Observational Study GroupStability of the Bone Flap After Fixationat dischargevery good15 Participants
Observational Study GroupStability of the Bone Flap After Fixationat dischargegood8 Participants
Observational Study GroupStability of the Bone Flap After Fixationat dischargeacceptable0 Participants
Observational Study GroupStability of the Bone Flap After Fixationat dischargecould not be evaluated1 Participants
Observational Study GroupStability of the Bone Flap After Fixationat follow up (3±2 monthsvery good11 Participants
Observational Study GroupStability of the Bone Flap After Fixationat follow up (3±2 monthsgood6 Participants
Observational Study GroupStability of the Bone Flap After Fixationat follow up (3±2 monthsacceptable0 Participants
Observational Study GroupStability of the Bone Flap After Fixationat follow up (3±2 monthscould not be evaluated0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026